At last, one tumor characteristic (TNM stage) and four immune variables (CD8, Foxp3, CD33, PD-L1-TC) had independent prognostic value for the OS of ESCC patients (Table 3). This evidence concerns the gene CD8A and esophageal squamous cell carcinoma.